Statement of Organization, Functions, and Delegations of Authority
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Secretary of Health and Human Services delegates to the National Institutes of Health (NIH) Director and the Food and Drug Administration (FDA) Commissioner the authorities vested in the Secretary of Health and Human Services under Section 3 of the Accelerating Access to Critical Therapies for ALS Act, as amended, to establish and implement a Public-Private Partnership for rare neurodegenerative diseases. These authorities may be redelegated. Exercise of this authority shall be in accordance with established policies, procedures, guidelines, and regulations as prescribed by the Secretary. The Secretary retains the authority to submit reports to Congress and promulgate regulations.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 231 (Friday, December 2, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 231 (Friday, December 2, 2022)]
[Notices]
[Page 74154]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-26280]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Food and Drug Administration
Statement of Organization, Functions, and Delegations of
Authority
AGENCY: National Institutes of Health and Food and Drug Administration,
HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Secretary of Health and Human Services delegates to the
National Institutes of Health (NIH) Director and the Food and Drug
Administration (FDA) Commissioner the authorities vested in the
Secretary of Health and Human Services under Section 3 of the
Accelerating Access to Critical Therapies for ALS Act, as amended, to
establish and implement a Public-Private Partnership for rare
neurodegenerative diseases. These authorities may be redelegated.
Exercise of this authority shall be in accordance with established
policies, procedures, guidelines, and regulations as prescribed by the
Secretary. The Secretary retains the authority to submit reports to
Congress and promulgate regulations.
DATES: This authority delegation was approved by the Secretary of
Health and Human Services on November, 29, 2022.
Dated: November 29, 2022.
Xavier Becerra,
Secretary, Department of Health and Human Services.
[FR Doc. 2022-26280 Filed 12-1-22; 8:45 am]
BILLING CODE 4140-01-P
</pre></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.